{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:46:18Z","timestamp":1790707578736,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11102-018-0918-y","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T07:08:44Z","timestamp":1540192124000},"page":"624-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy"],"prefix":"10.1007","volume":"21","author":[{"given":"Adnan","family":"Ajmal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"McKean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-0248","authenticated-orcid":false,"given":"Ariel","family":"Barkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"issue":"3","key":"918_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1210\/er.2004-0022","volume":"27","author":"LJ Woodhouse","year":"2006","unstructured":"Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S (2006) The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 27(3):287\u2013317. \n                    https:\/\/doi.org\/10.1210\/er.2004-0022","journal-title":"Endocr Rev"},{"issue":"2","key":"918_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ghir.2006.03.012","volume":"16","author":"K Chihara","year":"2006","unstructured":"Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A (2006) Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study. Growth Horm IGF Res 16(2):132\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.ghir.2006.03.012","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"918_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1210\/jc.2003-030346","volume":"89","author":"AR Hoffman","year":"2004","unstructured":"Hoffman AR, Kuntze JE, Baptista J, Baum HB, Baumann GP, Biller BM, Clark RV, Cook D, Inzucchi SE, Kleinberg D, Klibanski A, Phillips LS, Ridgway EC, Robbins RJ, Schlechte J, Sharma M, Thorner MO, Vance ML (2004) Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89(5):2048\u20132056. \n                    https:\/\/doi.org\/10.1210\/jc.2003-030346","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"918_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/eje.1.01971","volume":"153","author":"J Bollerslev","year":"2005","unstructured":"Bollerslev J, Hallen J, Fougner KJ, Jorgensen AP, Kristo C, Fagertun H, Gudmundsen O, Burman P, Schreiner T (2005) Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial. Eur J Endocrinol 153(3):379\u2013387. \n                    https:\/\/doi.org\/10.1530\/eje.1.01971","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"918_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11102-008-0126-2","volume":"11","author":"K Danilowicz","year":"2008","unstructured":"Danilowicz K, Bruno OD, Manavela M, Gomez RM, Barkan A (2008) Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 11(3):279\u2013285. \n                    https:\/\/doi.org\/10.1007\/s11102-008-0126-2","journal-title":"Pituitary"},{"key":"918_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1472-6823-12-8","volume":"12","author":"M Forss","year":"2012","unstructured":"Forss M, Batcheller G, Skrtic S, Johannsson G (2012) Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency\u2014a worldwide patient survey. BMC Endocr Disord 12:8. \n                    https:\/\/doi.org\/10.1186\/1472-6823-12-8","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"918_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1530\/EJE-14-0397","volume":"171","author":"O Ragnarsson","year":"2014","unstructured":"Ragnarsson O, Mattsson AF, Monson JP, Filipsson Nystrom H, Akerblad AC, Koltowska-Haggstrom M, Johannsson G (2014) The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients. Eur J Endocrinol 171(5):571\u2013579. \n                    https:\/\/doi.org\/10.1530\/EJE-14-0397","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"918_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/EJE-17-0340","volume":"177","author":"C Hammarstrand","year":"2017","unstructured":"Hammarstrand C, Ragnarsson O, Hallen T, Andersson E, Skoglund T, Nilsson AG, Johansson G, Olsson DS (2017) Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma. Eur J Endocrinol 177(3):251\u2013256. \n                    https:\/\/doi.org\/10.1530\/EJE-17-0340","journal-title":"Eur J Endocrinol"},{"key":"918_CR9","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1530\/EJE-17-0154","volume":"177","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, Giustina A (2017) Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 177:R231\u2013R248. \n                    https:\/\/doi.org\/10.1530\/EJE-17-0154","journal-title":"Eur J Endocrinol"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1748-717X-7-179","volume":"7","author":"E Lofdahl","year":"2012","unstructured":"Lofdahl E, Berg G, Johansson KA, Zachrisson ML, Malmgren H, Mercke C, Olsson E, Wiren L, Johannsson G (2012) Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region. Radiat Oncol 7:179\u2013188. \n                    https:\/\/doi.org\/10.1186\/1748-717X-7-179","journal-title":"Radiat Oncol"},{"issue":"2","key":"918_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","volume":"87","author":"ML Hartman","year":"2002","unstructured":"Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, Hypos CCSAB, Group, U.S.H.S (2002) Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87(2):477\u2013485. \n                    https:\/\/doi.org\/10.1210\/jcem.87.2.8216","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"918_CR12","first-page":"2350","volume":"83","author":"E Erturk","year":"1998","unstructured":"Erturk E, Jaffe CA,, Barkan AL. Evaluation of the integrity of the hypothalamic- pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 83(7), 2350\u20132354. (1998)","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"918_CR13","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. \n                    https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"918_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/jama.299.7.769","volume":"299","author":"J Jonklaas","year":"2008","unstructured":"Jonklaas J, Davidson B, Bhagat S, Soldin SJ (2008) Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299(7):769\u2013777. \n                    https:\/\/doi.org\/10.1001\/jama.299.7.769","journal-title":"JAMA"},{"issue":"4","key":"918_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1008987922774","volume":"8","author":"SP McKenna","year":"1999","unstructured":"McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, Wiren L (1999) The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 8(4):373\u2013383","journal-title":"Qual Life Res"},{"issue":"2","key":"918_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/alr.21008","volume":"2","author":"ED McCoul","year":"2012","unstructured":"McCoul ED, Anand VK, Bedrosian JC, Schwartz TH (2012) Endoscopic skull base surgery and its impact on sinonasal-related quality of life. Int Forum Allergy Rhinol 2(2):174\u2013181. \n                    https:\/\/doi.org\/10.1002\/alr.21008","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"918_CR17","first-page":"654","volume":"42","author":"MW Elmlinger","year":"2004","unstructured":"Elmlinger MW, Kuhnel W, Weber MM, Ranke MB (2004) Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF- binding protein 3 (IGFBP-3). Chem Lab Med 42(6):654\u2013664","journal-title":"Chem Lab Med"},{"issue":"4","key":"918_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1524-4733.2009.00689.x","volume":"13","author":"H Gilet","year":"2010","unstructured":"Gilet H, Chachuat A, Viala-Danten M, Auziere S, Koltowska-Haggstrom M (2010) Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study. Value Health 13(4):495\u2013500. \n                    https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00689.x","journal-title":"Value Health"},{"issue":"5","key":"918_CR19","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1210\/jcem.86.5.7443","volume":"86","author":"AL Barkan","year":"2001","unstructured":"Barkan AL (2001) The \u201cquality of life-assessment of growth hormone deficiency in adults\u201d questionnaire: can it be used to assess quality of life in hypopituitarism? J Clin Endocrinol Metab 86(5):1905\u20131907. \n                    https:\/\/doi.org\/10.1210\/jcem.86.5.7443","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"918_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1212\/WNL.59.1.121","volume":"59","author":"TJ Postma","year":"2002","unstructured":"Postma TJ, Klein M, Verstappen CC, Bromberg JE, Swennen M, Langendijk JA, Taphoorn MJ, Scheltens P, Slotman BJ, van der Ploeg HM, Aaronson NK, Heimans JJ (2002) Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 59(1):121\u2013123","journal-title":"Neurology"},{"issue":"1","key":"918_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/eje.1.02176","volume":"155","author":"M Koltowska-Haggstrom","year":"2006","unstructured":"Koltowska-Haggstrom M, Mattsson AF, Monson JP, Kind P, Badia X, Casanueva FF, Busschbach J, Koppeschaar HPF, Johannsson G (2006) Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? Eur J Endocrinol 155(1):109\u2013119. \n                    https:\/\/doi.org\/10.1530\/eje.1.02176","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"918_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/alr.21989","volume":"7","author":"HN Kuhar","year":"2017","unstructured":"Kuhar HN, Tajudeen BA, Heilingoetter A, Mahdavinia M, Gattuso P, Ghai R, Gunawan F, Diaz AZ, Tolekidis G, Batra PS (2017) Distinct histopathologic features of radiation-induced chronic sinusitis. Int Forum Allergy Rhinol 7(10):990\u2013998. \n                    https:\/\/doi.org\/10.1002\/alr.21989","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"918_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/1945892418765001","volume":"32","author":"KN Adams","year":"2018","unstructured":"Adams KN, Farquhar D, Senior BA, Thorp BD, Zanation AM, Ebert CS (2018) A pilot comparison between caregiver\u2019s and patient\u2019s perceived quality of life in chronic rhinosinusitis. Am J Rhinol Allergy 32(3):153\u2013159. \n                    https:\/\/doi.org\/10.1177\/1945892418765001","journal-title":"Am J Rhinol Allergy"},{"issue":"5","key":"918_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","volume":"34","author":"C Hopkins","year":"2009","unstructured":"Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP (2009) Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol 34(5):447\u2013454. \n                    https:\/\/doi.org\/10.1111\/j.1749-4486.2009.01995.x","journal-title":"Clin Otolaryngol"},{"issue":"12","key":"918_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/alr.21200","volume":"3","author":"BR Harrow","year":"2013","unstructured":"Harrow BR, Batra PS (2013) Sinonasal quality of life outcomes after minimally invasive resection of sinonasal and skull-base tumors. Int Forum Allergy Rhinol 3(12):1013\u20131020. \n                    https:\/\/doi.org\/10.1002\/alr.21200","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"918_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0194599814530858","volume":"151","author":"EE Alon","year":"2014","unstructured":"Alon EE, Lipschitz N, Bedrin L, Gluck I, Talmi Y, Wolf M, Yakirevitch A (2014) Delayed sino-nasal complications of radiotherapy for nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 151(2):354\u2013358. \n                    https:\/\/doi.org\/10.1177\/0194599814530858","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"918_CR27","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1210\/jcem.83.9.5112","volume":"83","author":"HB Baum","year":"1998","unstructured":"Baum HB, Katznelson L, Sherman JC, Biller BM, Hayden DL, Schoenfeld DA, Cannistraro KE, Klibanski A (1998) Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab 83(9):3184\u20133189. \n                    https:\/\/doi.org\/10.1210\/jcem.83.9.5112","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"918_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2265.1997.3041112.x","volume":"47","author":"J Verhelst","year":"1997","unstructured":"Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelst A, De Rijdt D, Stevenaert A, Beckers A (1997) Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 47(4):485\u2013494","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"918_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2265.1995.tb02601.x","volume":"42","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Freemantle C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG (1995) Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 42(1):73\u201384","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"918_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1210\/jcem.83.1.4482","volume":"83","author":"RC Cuneo","year":"1998","unstructured":"Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D (1998) The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 83(1):107\u2013116. \n                    https:\/\/doi.org\/10.1210\/jcem.83.1.4482","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"918_CR31","doi-asserted-by":"publisher","first-page":"E1264","DOI":"10.1152\/ajpendo.00320.2012","volume":"303","author":"AS Cornford","year":"2012","unstructured":"Cornford AS, Barkan AL, Hinko A, Horowitz JF (2012) Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk. Am J Physiol Endocrinol Metab 303(10):E1264\u2013E1272. \n                    https:\/\/doi.org\/10.1152\/ajpendo.00320.2012","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"918_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1507\/endocrj.K08E-311","volume":"56","author":"J Morita","year":"2009","unstructured":"Morita J, Hakuno F, Hizuka N, Takahashi S, Takano K (2009) Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates. Endocr J 56(4):561\u2013570","journal-title":"Endocr J"},{"issue":"11","key":"918_CR33","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1210\/jc.2004-1114","volume":"89","author":"C Giavoli","year":"2004","unstructured":"Giavoli C, Libe R, Corbetta S, Ferrante E, Lania A, Arosio M, Spada A, Beck-Peccoz P (2004) Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients. J Clin Endocrinol Metab 89(11):5397\u20135401. \n                    https:\/\/doi.org\/10.1210\/jc.2004-1114","journal-title":"J Clin Endocrinol Metab"},{"key":"918_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000321243","volume":"20","author":"SJ Neggers","year":"2011","unstructured":"Neggers SJ, van der Lely AJ (2011) Modulation of glucocorticoid metabolism by the GH-IGF-I axis. Endocr Dev 20:181\u2013186. \n                    https:\/\/doi.org\/10.1159\/000321243","journal-title":"Endocr Dev"},{"issue":"12","key":"918_CR35","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1210\/jc.2005-0928","volume":"90","author":"AR Hoffman","year":"2005","unstructured":"Hoffman AR, Biller BM, Cook D, Baptista J, Silverman BL, Dao L, Attie KM, Fielder P, Maneatis T, Lippe B, Genentech Adult Growth Hormone Deficiency Study G (2005) Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab 90(12):6431\u20136440. \n                    https:\/\/doi.org\/10.1210\/jc.2005-0928","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"918_CR36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1210\/jcem.81.5.8626817","volume":"81","author":"SP Taback","year":"1996","unstructured":"Taback SP, Dean HJ (1996) Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967\u20131992. The Canadian Growth Hormone Advisory Committee. J Clin Endocrinol Metab 81(5):1693\u20131696. \n                    https:\/\/doi.org\/10.1210\/jcem.81.5.8626817","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"918_CR37","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/EJE-18-0306","volume":"179","author":"JOL J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen JOL, Juul A, THERAPY OF ENDOCRINE DISEASE (2018) Growth hormone replacement therapy in adults: 30 years of personal clinical experience. Eur J Endocrinol 179(1):R47\u2013R56. \n                    https:\/\/doi.org\/10.1530\/EJE-18-0306","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-018-0918-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0918-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T20:16:57Z","timestamp":1571689017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-018-0918-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1007\/s11102-018-0918-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]},"assertion":[{"value":"22 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}